A2 Katsausartikkeli tieteellisessä aikausilehdessä
Therapeutic targets for enterovirus infections (2020)
Laajala, M., Reshamwala, D., & Marjomäki, V. (2020). Therapeutic targets for enterovirus infections. Expert Opinion On Therapeutic Targets, 24(8), 745-757. https://doi.org/10.1080/14728222.2020.1784141
JYU-tekijät tai -toimittajat
Julkaisun tiedot
Julkaisun kaikki tekijät tai toimittajat: Laajala, Mira; Reshamwala, Dhanik; Marjomäki, Varpu
Lehti tai sarja: Expert Opinion On Therapeutic Targets
ISSN: 1472-8222
eISSN: 1744-7631
Julkaisuvuosi: 2020
Volyymi: 24
Lehden numero: 8
Artikkelin sivunumerot: 745-757
Kustantaja: Taylor & Francis
Julkaisumaa: Britannia
Julkaisun kieli: englanti
DOI: https://doi.org/10.1080/14728222.2020.1784141
Julkaisun avoin saatavuus: Ei avoin
Julkaisukanavan avoin saatavuus:
Tiivistelmä
Enteroviruses are among the most common viruses causing a huge number of acute and chronic infections leading to high economic costs. Novel non-toxic antivirals that reduce the virus load in acutely infected individuals and from various surfaces are needed to efficiently combat these viruses.
Areas covered
This review summarizes the recent findings of compounds and tools targeting the enteroviruses and host cell molecules that are crucial for virus infection. In addition, the review states the modern methods to find new targets and tools that help to understand the mechanisms of action.
Expert opinion
High throughput molecular screens have revealed important aspects of virus life cycle in host cells and, concomitantly, some of the targets and compounds found serve as potential anti-virals combatting enterovirus infections. The risk of resistance development found for direct capsid binders lowers their usefulness, but combining them with compounds targeting evolutionarily conserved processes such as replication/translation makes them potentially a valid therapy for the future. Further automation and access to structural molecular tools such as cryo-EM and further development of e.g. docking and simulation of large virus particles requiring heavy computation will contribute to better understanding of molecular mechanisms of action of future antivirals.
YSO-asiasanat: virukset; enterovirukset; infektiot; infektiotaudit; lääkkeet; lääkehoito; resistanssi; isäntäsolut
Vapaat asiasanat: antiviraaliset lääkkeet
Liittyvät organisaatiot
Hankkeet, joissa julkaisu on tehty
- Novel probes fordiscovering anti-virals
- Marjomäki, Varpu
- Jane ja Aatos Erkon säätiö
OKM-raportointi: Kyllä
Raportointivuosi: 2020
JUFO-taso: 1